These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29592953)

  • 1. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.
    Sareddy GR; Li X; Liu J; Viswanadhapalli S; Garcia L; Gruslova A; Cavazos D; Garcia M; Strom AM; Gustafsson JA; Tekmal RR; Brenner A; Vadlamudi RK
    Sci Rep; 2016 Apr; 6():24185. PubMed ID: 27126081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ERβ hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.
    Wang D; Tang M; Zhang P; Yang K; Huang L; Wu M; Shen Q; Yue J; Wang W; Gong Y; Warner M; Dai L; He H; Yang Z; Gustafsson JA; Zhou S
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2306814121. PubMed ID: 38513102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
    He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307.
    Pontecorvi G; Bellenghi M; Tait S; Tirelli V; Matarrese P; Mattia G; Carè A; Puglisi R
    J Cancer; 2022; 13(5):1573-1587. PubMed ID: 35371312
    [No Abstract]   [Full Text] [Related]  

  • 6. Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men.
    Hu L; Jin Y; Li YG; Borel A
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):305-14. PubMed ID: 27136911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist.
    Hilbish KG; Breslin WJ; Johnson JT; Sloter ED
    Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):400-15. PubMed ID: 24323950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
    Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
    Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
    Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
    J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
    Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
    Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
    Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
    Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.
    Bouchard G; Therriault H; Bujold R; Saucier C; Paquette B
    Int J Radiat Biol; 2017 May; 93(5):507-516. PubMed ID: 27935337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.
    Desbois M; Béal C; Charrier M; Besse B; Meurice G; Cagnard N; Jacques Y; Béchard D; Cassard L; Chaput N
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32532840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
    Xiao Y; Cong M; Li J; He D; Wu Q; Tian P; Wang Y; Yang S; Liang C; Liang Y; Wen J; Liu Y; Luo W; Lv X; He Y; Cheng DD; Zhou T; Zhao W; Zhang P; Zhang X; Xiao Y; Qian Y; Wang H; Gao Q; Yang QC; Yang Q; Hu G
    Cancer Cell; 2021 Mar; 39(3):423-437.e7. PubMed ID: 33450198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs.
    Sharma SK; Chintala NK; Vadrevu SK; Patel J; Karbowniczek M; Markiewski MM
    J Immunol; 2015 Jun; 194(11):5529-38. PubMed ID: 25911761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.